Accenture Ventures Makes Strategic Investment in Turbine

May 17, 2024

Accenture, through Accenture Ventures, made a strategic growth investment in Turbine, a Budapest-based company that builds AI-driven predictive simulation software for interpreting human biology to accelerate drug discovery. The investment will help Turbine expand its platform to global biopharma clients and integrate its Simulated Cell technology into larger drug-development workflows; terms were not disclosed.

Targets
Turbine
Industry
Biotechnology
Location
Budapest, Hungary
Transaction Type
Growth capital

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.